Aflac (AFL)
(Real Time Quote from BATS)
$94.20 USD
+1.29 (1.39%)
Updated Jul 22, 2024 02:32 PM ET
4-Sell of 5 4
D Value C Growth D Momentum D VGM
Aflac (AFL) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$85.79 | $105.00 | $75.00 | -7.66% |
Price Target
Based on short-term price targets offered by 14 analysts, the average price target for Aflac comes to $85.79. The forecasts range from a low of $75.00 to a high of $105.00. The average price target represents a decline of 7.66% from the last closing price of $92.91.
Analyst Price Targets (14)
Broker Rating
Aflac currently has an average brokerage recommendation (ABR) of 3.06 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 16 brokerage firms. The current ABR compares to an ABR of 3.07 a month ago based on 15 recommendations.
Of the 16 recommendations deriving the current ABR, two are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 12.5% and 6.25% of all recommendations. A month ago, Strong Buy made up 13.33%, while Buy represented 6.67%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/AFL.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 10 | 9 | 9 | 9 | 9 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 3 | 3 | 3 | 2 | 2 |
ABR | 3.06 | 3.07 | 3.07 | 2.93 | 2.93 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/11/2024 | Wells Fargo Securities | Elyse Greenspan | Hold | Hold |
7/9/2024 | Dowling & Partners | Joel Hurwitz | Not Available | Hold |
6/28/2024 | Piper Sandler | John Barnidge | Strong Buy | Strong Buy |
6/28/2024 | Not Identified | Not Identified | Hold | Hold |
5/20/2024 | Not Identified | Not Identified | Not Available | Strong Sell |
5/2/2024 | Not Identified | Not Identified | Hold | Hold |
5/2/2024 | Truist Securities | Mark D Hughes | Hold | Hold |
4/10/2024 | Keefe Bruyette & Woods | Ryan Krueger | Hold | Hold |
2/2/2024 | Raymond James | Wilma Burdis | Moderate Buy | Moderate Buy |
1/30/2024 | Not Identified | Not Identified | Hold | Hold |
1/11/2024 | UBS | Brian R Meredith | Not Available | Hold |
1/9/2024 | Goldman Sachs | Alex Scott | Not Available | Strong Sell |
1/4/2024 | Evercore Partners | Thomas Gallagher | Hold | Strong Sell |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.06 |
ABR (Last week) | 3.07 |
# of Recs in ABR | 16 |
Average Target Price | $85.79 |
LT Growth Rate | 5.70% |
Industry | Insurance - Accident and Health |
Industry Rank by ABR | 186 of 252 |
Current Quarter EPS Est: | 1.59 |